188 related articles for article (PubMed ID: 36555726)
1. The Effects of One-Point Mutation on the New Delhi Metallo Beta-Lactamase-1 Resistance toward Carbapenem Antibiotics and β-Lactamase Inhibitors: An In Silico Systematic Approach.
Tran VT; Tran VH; Nguyen DN; Do TG; Vo TP; Nguyen TT; Huynh PNH; Thai KM
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555726
[TBL] [Abstract][Full Text] [Related]
2. Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria.
Guo Y; Liu H; Yang M; Ding R; Gao Y; Niu X; Deng X; Wang J; Feng H; Qiu J
Br J Pharmacol; 2024 Jan; 181(1):54-69. PubMed ID: 37539785
[TBL] [Abstract][Full Text] [Related]
3. Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design.
Linciano P; Cendron L; Gianquinto E; Spyrakis F; Tondi D
ACS Infect Dis; 2019 Jan; 5(1):9-34. PubMed ID: 30421910
[TBL] [Abstract][Full Text] [Related]
4. Structure-guided optimization of D-captopril for discovery of potent NDM-1 inhibitors.
Ma G; Wang S; Wu K; Zhang W; Ahmad A; Hao Q; Lei X; Zhang H
Bioorg Med Chem; 2021 Jan; 29():115902. PubMed ID: 33302045
[TBL] [Abstract][Full Text] [Related]
5. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.
Muteeb G; Alsultan A; Farhan M; Aatif M
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073
[TBL] [Abstract][Full Text] [Related]
6. Molecular and computational approaches to understand resistance of New Delhi metallo β-lactamase variants (NDM-1, NDM-4, NDM-5, NDM-6, NDM-7)-producing strains against carbapenems.
Ali A; Gupta D; Srivastava G; Sharma A; Khan AU
J Biomol Struct Dyn; 2019 May; 37(8):2061-2071. PubMed ID: 29749296
[TBL] [Abstract][Full Text] [Related]
7. High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.
Rehman MT; AlAjmi MF; Hussain A; Rather GM; Khan MA
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769822
[TBL] [Abstract][Full Text] [Related]
8.
Rahman M; Khan MKA
J Biomol Struct Dyn; 2020 Apr; 38(7):2093-2103. PubMed ID: 31184285
[TBL] [Abstract][Full Text] [Related]
9. Fluorinated captopril analogues inhibit metallo-β-lactamases and facilitate structure determination of NDM-1 binding pose.
Kondratieva A; Palica K; Frøhlich C; Hovd RR; Leiros HS; Erdelyi M; Bayer A
Eur J Med Chem; 2024 Feb; 266():116140. PubMed ID: 38242072
[TBL] [Abstract][Full Text] [Related]
10. Pterostilbene restores carbapenem susceptibility in New Delhi metallo-β-lactamase-producing isolates by inhibiting the activity of New Delhi metallo-β-lactamases.
Liu S; Zhang J; Zhou Y; Hu N; Li J; Wang Y; Niu X; Deng X; Wang J
Br J Pharmacol; 2019 Dec; 176(23):4548-4557. PubMed ID: 31376166
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Potential Inhibitor (MCULE-8777613195-0-12) of New Delhi Metallo-β-Lactamase-1 (NDM-1) Using In Silico and In Vitro Approaches.
Muteeb G; Rehman MT; AlAjmi MF; Aatif M; Farhan M; Shafi S
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144666
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic and
Moreira JS; Galvão DS; Xavier CFC; Cunha S; Pita SSDR; Reis JN; Freitas HF
J Biomol Struct Dyn; 2022; 40(24):14223-14235. PubMed ID: 34766882
[TBL] [Abstract][Full Text] [Related]
13. SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model.
Leiris S; Coelho A; Castandet J; Bayet M; Lozano C; Bougnon J; Bousquet J; Everett M; Lemonnier M; Sprynski N; Zalacain M; Pallin TD; Cramp MC; Jennings N; Raphy G; Jones MW; Pattipati R; Shankar B; Sivasubrahmanyam R; Soodhagani AK; Juventhala RR; Pottabathini N; Pothukanuri S; Benvenuti M; Pozzi C; Mangani S; De Luca F; Cerboni G; Docquier JD; Davies DT
ACS Infect Dis; 2019 Jan; 5(1):131-140. PubMed ID: 30427656
[TBL] [Abstract][Full Text] [Related]
14. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
[TBL] [Abstract][Full Text] [Related]
15. Structural and biochemical analysis of the metallo-β-lactamase L1 from emerging pathogen Stenotrophomonas maltophilia revealed the subtle but distinct di-metal scaffold for catalytic activity.
Kim Y; Maltseva N; Wilamowski M; Tesar C; Endres M; Joachimiak A
Protein Sci; 2020 Mar; 29(3):723-743. PubMed ID: 31846104
[TBL] [Abstract][Full Text] [Related]
16.
Cheepurupalli L; Diaz A; Gopal AC; Rathore SS; Ramakrishnan V; Ramakrishnan J
J Biomol Struct Dyn; 2022; 40(24):13593-13605. PubMed ID: 34657563
[TBL] [Abstract][Full Text] [Related]
17. Stereochemically altered cephalosporins as potent inhibitors of New Delhi metallo-β-lactamases.
Hu L; Yang H; Yu T; Chen F; Liu R; Xue S; Zhang S; Mao W; Ji C; Wang H; Xie H
Eur J Med Chem; 2022 Mar; 232():114174. PubMed ID: 35152091
[TBL] [Abstract][Full Text] [Related]
18.
Vasudevan A; Kesavan DK; Wu L; Su Z; Wang S; Ramasamy MK; Hopper W; Xu H
Biomed Res Int; 2022; 2022():4230788. PubMed ID: 35372567
[TBL] [Abstract][Full Text] [Related]
19. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.
Deshpande P; Rodrigues C; Shetty A; Kapadia F; Hedge A; Soman R
J Assoc Physicians India; 2010 Mar; 58():147-9. PubMed ID: 20848811
[TBL] [Abstract][Full Text] [Related]
20. Structural Basis of Metallo-β-Lactamase Inhibition by Captopril Stereoisomers.
Brem J; van Berkel SS; Zollman D; Lee SY; Gileadi O; McHugh PJ; Walsh TR; McDonough MA; Schofield CJ
Antimicrob Agents Chemother; 2016 Jan; 60(1):142-50. PubMed ID: 26482303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
